Calumet (CLMT) Q3 2025 earnings summary

Executive summary

• Achieved $92.5 million of adjusted EBITDA with tax attributes in Q3 2025, up from $59.8 million in Q3 2024, marking the strongest quarter in years and reflecting both financial and strategic progress.

• Net income reached $313.4 million and basic EPS was $3.61 for Q3 2025, a significant turnaround from a net loss of $100.6 million in Q3 2024.

• Company-wide cost reduction initiatives delivered $61 million in operating cost savings year-to-date, with quarterly operating cost reductions of $24 million versus last year.

• Montana Renewables' MaxSAF expansion remains on schedule for Q2 2026, with 100 million gallons already contracted or in advanced DOE review.

• Specialty Products & Solutions achieved record production and continued margin strength, with commercial teams selling over 20,000 barrels/day at margins above $60/barrel.

Financial highlights

• Q3 2025 sales were $1,078.0 million, slightly down from $1,100.4 million in Q3 2024.

• Gross profit for Q3 2025 was $373.7 million, up from $4.9 million in Q3 2024.

• Adjusted EBITDA for Q3 2025 was $92.5 million, with Specialty Products & Solutions contributing $80.2 million, up from $50.7 million year-over-year.

• Montana Renewables generated $17.1 million adjusted EBITDA with tax attributes, up from $14.6 million in the prior year.

• Reduced restricted group debt by over $40 million during the quarter, supporting ongoing deleveraging efforts.

Outlook and guidance

• MaxSAF expansion is on track for Q2 2026, with robust SAF demand and 100 million gallons of contracts secured.

• Expect continued deleveraging in Q4 and strong free cash flow generation to conclude 2025.

• Regulatory support for biofuels remains strong, with EPA decisions on RVO and SRE reallocation pending.

• SAF premiums of $1–$2/gallon expected, with operations ready for 2026 startup.

• Ongoing focus on operational improvements and cost reductions across all segments.